4//SEC Filing
ABALLI JOHN 4
Accession 0001274737-23-000094
CIK 0001274737other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:05 PM ET
Size
4.8 KB
Accession
0001274737-23-000094
Insider Transaction Report
Form 4
EXAGEN INC.XGN
ABALLI JOHN
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-10-17$1.75/sh−33,819$59,018→ 415,984 total
Footnotes (1)
- [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on October 16, 2022.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001843113
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:05 PM ET
- Size
- 4.8 KB